沐舒坦佐治早产儿肺炎疗效评价

TO evaluae the effect by using ambroxol in preterm infants with Pneumonia

目的：了解沐舒坦治疗早产儿肺炎的疗效。方法：68例早产儿肺炎患者随机分成治疗组36例,对照组32例。两组均采用常规治疗。治疗组加用沐舒坦30mg/kg·d,分为两次,共用3d,同时监测血气。结果：治疗组在改善症状,消除肺部体征及提高疗效率等方面均优于对照组,同时血气恢复正常优于对照组（p均〉0.05）。结论：沐舒坦治疗早产儿肺炎疗效显著,未发现明显副作用。

Obejctive：TO investigate the effect of the ambroxol in helping cure Pneumonia of preterm infants. Methods 68 of preterm infants with Pneumonia were randomly divided into the treatment group（36 cases） and the control group （32 cases） The patients in treatment group were treated by adding ambroxol with dose at 30mg/kg, d, 2 times for 3 days, At the same time, the blood gas were monitored. Results The result showed the treatment group was better than the control group in improving symptoms of pneumonia, removing rales in lungs and enhancing cure rate. The normal convalescence of blood gas was more excellent than that of the control group. Conclusions The curatives of ambroxol in the treatment of preterm infants with Pneumonia is marked and not any side--effeets were found.